2004
DOI: 10.1590/s1415-47572004000300004
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein E polymorphism as a predictor for cognitive decline and dementia in the Saudi general population over 65 years

Abstract: Specific Apolipoprotein E (ApoE) genotypes are thought to be associated with risk for Alzheimer's disease (AD). It is essential to understand how this genetic factor affects cognitive decline and dementia in the general population. One hundred and fifty elderly persons residing at social nursing centers in different provinces of Saudi Arabia were tested for ApoE genotypes, using PCR amplification of genomic DNA followed by DNA digestion with Cfo I. All subjects were diagnosed with regard to cognitive decline a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 28 publications
1
1
0
Order By: Relevance
“…Among the resulted five genotypes E3/E3 was the most prevalent genotype ( 63%) and the lowest was E2lE4 (1%) while the prevalence of E3/E4, E2/E3 and E4/E4 genotypes were 25%,8.5% and 2.5% respectively. These genotypes prevalence's are concordant with the results among different population such as Nigerians (44); African Americans [45]; American Indian [46]; Caucasians [47]; Germany [48]; Finland [49]; France [50]; Italy [51]; Chinese [52]; Japanese [53] and Swedish [18]. In comparison with previously published Saudi studies, there are three published studies demonstrate apoE genotypes prevalence and allele frequencies with general population over 65 years [54]; with normal individuals [55] and with primary glaucoma Saudi patients [19].…”
Section: Discussionsupporting
confidence: 87%
“…Among the resulted five genotypes E3/E3 was the most prevalent genotype ( 63%) and the lowest was E2lE4 (1%) while the prevalence of E3/E4, E2/E3 and E4/E4 genotypes were 25%,8.5% and 2.5% respectively. These genotypes prevalence's are concordant with the results among different population such as Nigerians (44); African Americans [45]; American Indian [46]; Caucasians [47]; Germany [48]; Finland [49]; France [50]; Italy [51]; Chinese [52]; Japanese [53] and Swedish [18]. In comparison with previously published Saudi studies, there are three published studies demonstrate apoE genotypes prevalence and allele frequencies with general population over 65 years [54]; with normal individuals [55] and with primary glaucoma Saudi patients [19].…”
Section: Discussionsupporting
confidence: 87%
“…The differences in the prevalence of E3/E3 and E3/E4 in persons with and without dementia were nonsignificant (p= 0.2015). Other genotypes with an E2 allele were absent in the tested population (Al-Khedhairy, 2004). …”
Section: Disucssionmentioning
confidence: 92%